• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌患者的T细胞表现出κB特异性DNA结合活性的异常模式:初步报告。

T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.

作者信息

Li X, Liu J, Park J K, Hamilton T A, Rayman P, Klein E, Edinger M, Tubbs R, Bukowski R, Finke J

机构信息

Department of Immunology, Cleveland Clinic Foundation, Ohio 44195.

出版信息

Cancer Res. 1994 Oct 15;54(20):5424-9.

PMID:7923175
Abstract

Recent data suggest that the poor induction of a T-cell response to human renal cell carcinoma (RCC) may be related to alterations in signal transduction pathways. We report that T cells from RCC patients have two alterations in kappa B motif-specific DNA-binding activity. The first alteration involves the constitutive expression of substantial kappa B-binding activity in nuclear extracts, which was observed in the electrophoretic mobility shift assay. The magnitude of kappa B activity in unstimulated patient T cells was similar to that observed in T cells from normal individuals that had been activated in vitro. On the basis of Western blotting experiments using antibodies to kappa B/Rel family proteins, the kappa B-binding activity constitutively expressed in T cells from RCC patients is composed mostly of the NF-kappa B1 (p50) subunit. The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation. Western blotting analysis did not detect any RelA in nuclear extracts either before or after stimulation of T cells. The altered kappa B-binding activity in T cells from RCC patients may impair their capacity to respond normally to various stimuli.

摘要

最近的数据表明,人类肾细胞癌(RCC)患者T细胞反应诱导不佳可能与信号转导通路的改变有关。我们报告称,RCC患者的T细胞在κB基序特异性DNA结合活性方面存在两种改变。第一种改变涉及核提取物中大量κB结合活性的组成性表达,这在电泳迁移率变动分析中观察到。未受刺激的患者T细胞中κB活性的大小与体外激活的正常个体T细胞中观察到的相似。基于使用针对κB/Rel家族蛋白的抗体进行的蛋白质印迹实验,RCC患者T细胞中组成性表达的κB结合活性主要由NF-κB1(p50)亚基组成。这些患者T细胞中κB结合活性的第二个异常是,作为正常NF-κB复合物一部分的Rel同源家族成员RelA在激活后未在细胞核中被诱导。蛋白质印迹分析在T细胞刺激前后的核提取物中均未检测到任何RelA。RCC患者T细胞中κB结合活性的改变可能会损害它们对各种刺激正常反应的能力。

相似文献

1
T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.肾细胞癌患者的T细胞表现出κB特异性DNA结合活性的异常模式:初步报告。
Cancer Res. 1994 Oct 15;54(20):5424-9.
2
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.晚期肾癌患者T淋巴细胞中的信号转导异常:细胞因子治疗的临床相关性及效果
Clin Cancer Res. 1998 Oct;4(10):2337-47.
3
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.核因子-κB RelA转录因子在人胰腺腺癌细胞中持续激活。
Clin Cancer Res. 1999 Jan;5(1):119-27.
4
Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy.荷瘤小鼠脾脏T细胞中NF-κB/Rel家族蛋白的改变及治疗后的逆转
Cancer Res. 1994 Jun 1;54(11):2969-72.
5
Long-term inositol phosphate release, but not tyrosine kinase activity, correlates with IL-2 secretion and NF-AT induction in anti-CD3-activated peripheral human T lymphocytes.在抗CD3激活的人外周血T淋巴细胞中,长期的肌醇磷酸释放与白细胞介素-2分泌及活化T细胞核因子诱导相关,但与酪氨酸激酶活性无关。
Cell Immunol. 1994 Aug;157(1):158-69. doi: 10.1006/cimm.1994.1213.
6
CD30 ligation induces nuclear factor-kappa B activation in human T cell lines.CD30 连接可诱导人 T 细胞系中的核因子-κB 激活。
Eur J Immunol. 1995 Oct;25(10):2870-6. doi: 10.1002/eji.1830251024.
7
Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.系统性红斑狼疮患者T淋巴细胞中异常的核因子κB活性与p65-RelA蛋白表达降低有关。
J Immunol. 1999 Aug 1;163(3):1682-9.
8
Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.核因子κB的RelA(p65)和c-Rel亚基在肿瘤坏死因子相关凋亡诱导配体信号传导中的不同作用。
Cancer Res. 2003 Mar 1;63(5):1059-66.
9
Cell cycle regulation of NF-kappa b-binding activity in cells from human glioblastomas.人胶质母细胞瘤细胞中核因子-κB结合活性的细胞周期调控
Exp Cell Res. 2001 May 1;265(2):221-33. doi: 10.1006/excr.2001.5168.
10
IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes.白细胞介素-10抑制CD3刺激的人外周血T淋巴细胞中核因子-κB/Rel的核活性。
J Immunol. 1996 Mar 15;156(6):2119-23.

引用本文的文献

1
NF-κB in inflammation and cancer.炎症与癌症中的核因子-κB
Cell Mol Immunol. 2025 Jun 25. doi: 10.1038/s41423-025-01310-w.
2
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.NF-κB 亚基 RelA 和 c-Rel 选择性地控制多发性硬化症和癌症中的 CD4+ T 细胞功能。
J Exp Med. 2024 Jun 3;221(6). doi: 10.1084/jem.20231348. Epub 2024 Apr 2.
3
NF-κB in Cancer Immunity: Friend or Foe?NF-κB 在癌症免疫中的作用:是敌是友?
Cells. 2021 Feb 9;10(2):355. doi: 10.3390/cells10020355.
4
Arginase: A Multifaceted Enzyme Important in Health and Disease.精氨酸酶:一种在健康和疾病中具有重要作用的多功能酶。
Physiol Rev. 2018 Apr 1;98(2):641-665. doi: 10.1152/physrev.00037.2016.
5
Challenges and future perspectives of T cell immunotherapy in cancer.T细胞免疫疗法在癌症治疗中的挑战与未来展望
Immunol Lett. 2015 Aug;166(2):117-33. doi: 10.1016/j.imlet.2015.05.018. Epub 2015 Jun 19.
6
Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.髓源性抑制细胞在癌症中对 L-精氨酸的代谢:T 细胞抑制的机制和治疗前景。
Immunol Invest. 2012;41(6-7):614-34. doi: 10.3109/08820139.2012.680634.
7
Targeted therapy in renal cancer.肾癌的靶向治疗。
Ther Adv Med Oncol. 2009 Nov;1(3):183-205. doi: 10.1177/1758834009349119.
8
Signaling defects in anti-tumor T cells.抗肿瘤T细胞中的信号缺陷。
Immunol Rev. 2008 Apr;222:192-205. doi: 10.1111/j.1600-065X.2008.00606.x.
9
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.髓源性抑制细胞对精氨酸的调节与癌症中的耐受性:机制与治疗前景
Immunol Rev. 2008 Apr;222:180-91. doi: 10.1111/j.1600-065X.2008.00608.x.
10
Immune escape for renal cell carcinoma: CD70 mediates apoptosis in lymphocytes.肾细胞癌的免疫逃逸:CD70介导淋巴细胞凋亡。
Neoplasia. 2006 Nov;8(11):933-8. doi: 10.1593/neo.06451.